# Healthcare Services Group, Inc. (HCSG)

> Source: Nexqual · https://nexqual.com/HCSG · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Healthcare Services Group, Inc. (HCSG), nexqual.com/HCSG" · informational, not investment advice.

**Price:** USD 21.43 (+1.95% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 21.02 · day 21.18–21.67 · 52w 16.09–25.75 · market cap $1.47B · NMS

## Key facts
- Last four reported quarters (through Jun 30, 2026): revenue $1.86B, net income $123M (6.6% margin), free cash flow $149M (SEC filings).
- Valuation: P/E 12.0x (avg 21.8x at the last 3 fiscal year-ends).
- 1 of 80 tracked superinvestors hold HCSG (13F, Q2 2026): 0 new, 1 added, 0 reduced, 0 unchanged.
- Analysts: Buy (mean 2.43 on a 1–5 scale) (7 analysts), mean target USD 26.67 (range 24–30).
- Total return with dividends: 1Y +30.5% vs S&P 500 +18.1%; 5Y +0.9% vs S&P 500 +85.1%.
- Next earnings: 2026-10-21, EPS estimate USD 0.24, revenue estimate $481M.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $1.64B | $1.69B | $1.67B | $1.72B | $1.84B | $1.86B |
| Gross profit | $231M | $193M | $215M | $228M | $239M | — |
| Net income | $48.5M | $34.2M | $38.4M | $39.5M | $59.1M | $123M |
| EPS (diluted) | $0.65 | $0.46 | $0.52 | $0.53 | $0.81 | — |
| Free cash flow | $31.4M | -$13.4M | $38.1M | $24.5M | $139M | $149M |
| Gross margin | 14.0% | 11.4% | 12.8% | 13.3% | 13.0% | — |
| Net margin | 3.0% | 2.0% | 2.3% | 2.3% | 3.2% | 6.6% |
| Revenue growth | -6.7% | +2.9% | -1.1% | +2.7% | +7.1% | — |
| Cash + short-term investments | $185M | $121M | $147M | $107M | $168M | — |
Fiscal years end Dec. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Jun 30, 2026)
P/E 12.0x · P/S 0.8x · P/FCF 9.9x · P/B 2.8x · FCF yield 10.10% · Earnings yield 8.36% · Buyback yield (TTM) 6.24%
P/E at fiscal year-ends: Dec 2025 23.6x, Dec 2024 21.8x, Dec 2023 20.1x.

## Superinvestors (SEC 13F-HR, Q2 2026)
1 of 80 tracked investors hold HCSG. Change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| First Eagle Investment | First Eagle Investment Management | 0.02% | $13.5M | Added +15.5% |

## Analysts
Consensus Buy (mean 2.43 on a 1–5 scale), 7 analysts; mean target USD 26.67 (low 24, high 30).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-08 | Baird | Target lowered | Neutral | $26 → $24 |
| 2026-08-19 | Oppenheimer | Initiated | Outperform | $28 |
| 2026-07-08 | UBS | Target raised | Buy | $27 → $30 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | +30.5% | +0.9% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | +30.6% | +0.2% |
| Volatility (annualized) | 40.4% | 41.4% |
| Max drawdown | -19.9% (Feb 2026→Apr 2026) | -56.2% (Oct 2021→Jan 2024) |

## Peers (Medical Care Facilities)
AMN (AMN Healthcare Services Inc) USD 40 +9.47% · PNTG (The Pennant Group, Inc.) USD 42.27 +5.28% · AGL (agilon health, inc.) USD 88.45 +2.97% · NUTX (Nutex Health Inc.) USD 200.8 -1.74% · CMPS (COMPASS Pathways Plc - American) USD 11.62 +4.31% · USPH (U.S. Physical Therapy, Inc.) USD 85.98 +0.63%

## More
Full page: https://nexqual.com/HCSG · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt